<?xml version="1.0" encoding="UTF-8"?>
<lom xmlns="http://ltsc.ieee.org/xsd/LOM" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://ltsc.ieee.org/xsd/LOM http://standards.ieee.org/reading/ieee/downloads/LOM/lomv1.0/xsd/lom.xsd">
<general>
<title>
<string language="el">Facile and Efficient Syntheses of a Series of N-Benzyl and N-Biphenylmethyl Substituted Imidazole Derivatives Based on (E)-Urocanic acid, as Angiotensin II AT1 Receptor Blockers</string>
</title>
<language>eng</language>
<identifier>
<catalog>URI</catalog>
<entry>http://hdl.handle.net/10795/3343</entry>
</identifier>
<subject>
<string language="el">φυσικές επιστήμες</string>
<string language="el">χημεία</string>
<string language="el">ιατρικές επιστήμες</string>
<string language="el">ασθένεια του νευρικού συστήματος</string>
<string language="el">προσομοίωση</string>
<string language="el">φαρμακευτική</string>
</subject>
<description>
<string language="el">In the present work, a facile and efficient route for the synthesis of a series of N-substituted imidazole derivatives is described. Docking studies have revealed that N-substituted imidazole derivatives based on (E)-urocanic acid may be potential antihypertensive leads. Therefore, new AT1 receptor blockers bearing either the benzyl or the biphenylmethyl moiety at the N-1 or N-3 position, either the (E)-acrylate or the propanoate fragment and their related acids at the C-4 position as well as a halogen atom at the C-5 position of the imidazole ring, were synthesized. The newly synthesized analogues were evaluated for binding to human AT1 receptor. The biological results showed that this class of molecules possesses moderate or no activity, thus not always confirming high docking scores. Nonetheless, important conclusions can be derived for their molecular basis of their mode of action and help medicinal chemists to design and synthesize more potent ones. An aliphatic group as in losartan seems to be important for enhancing binding affinity and activity.</string>
</description>
<description>
<string language="el">23 pp.</string>
</description>
</general>
<lifecCycle>
<contribute>
<source>LOMv1.0</source>
<value>creator</value>
<entity><![CDATA[BEGIN:VCARD
FN: Agelis, George
N: Agelis, George
"VERSION:3.0"
END:VCARD]]></entity>
</contribute>
<contribute>
<source>LOMv1.0</source>
<value>publisher</value>
<entity><![CDATA[BEGIN:VCARD
FN: MDPI
N: MDPI
"VERSION:3.0"
END:VCARD]]></entity>
<contribute>
<contribute>
<source>LOMv1.0</source>
<value>Scientific Coordinator</value>
<entity><![CDATA[BEGIN:VCARD
FN: Μαυρομούστακος, Θωμάς
N: Μαυρομούστακος, Θωμάς
"VERSION:3.0"
END:VCARD]]></entity>
</contribute>
<contribute>
<source>LOMv1.0</source>
<value>Project Executing Organisation</value>
<entity><![CDATA[BEGIN:VCARD
FN: Εθνικό και Καποδιστριακό Πανεπιστήμιο Αθηνών (ΕΚΠΑ)
N: Εθνικό και Καποδιστριακό Πανεπιστήμιο Αθηνών (ΕΚΠΑ)
"VERSION:3.0"
END:VCARD]]></entity>
</contribute>
<date>
<dateStamp>2013-06-27</dateStamp>
</date>
</lifecCycle>
<educational>
<learningResourceType>
<source>Digital Library of the Operational Programme "Education and Lifelong Learning" abstract types</source>
<value>Text</value>
</learningResourceType>
</educational><classification><keyword>
<string language="el">synthesis</string>
</keyword>
<keyword>
<string language="el">AT1 receptor blockers</string>
</keyword>
<keyword>
<string language="el">(E)-urocanic acid</string>
</keyword>
<keyword>
<string language="el">N-alkylation</string>
</keyword>
<keyword>
<string language="el">docking studies</string>
</keyword>
</classification>
<technical>
</technical>
<technical>
<size>2137570</size>
<format>application/pdf</format>
<location>http://repository.edulll.gr/edulll/bitstream/10795/3343/2/3343_1.153_%ce%94%ce%97%ce%9c_18_6_14.pdf</location>
</technical>
<annotation></annotation><metaMetadata><identifier>
<catalog>URI</catalog>
<entry>http://hdl.handle.net/10795/3343</entry>
</identifier>
<contribute>
<entity><![CDATA[BEGIN:VCARD
FN:National Documentation Centre - National Hellenic Research Foundation
N:National Documentation Centre - National Hellenic Research Foundation
"VERSION:3.0"
END:VCARD]]></entity>
<role><source>LOMv1.0</source><value>creator</value></role>
<date><dateTime>2016-05-23T11:37:19Z</dateTime></date>
</contribute>
<contribute>
<entity><![CDATA[BEGIN:VCARD
FN:National Documentation Centre - National Hellenic Research Foundation
N:National Documentation Centre - National Hellenic Research Foundation
"VERSION:3.0"
END:VCARD]]></entity>
<role><source>LOMv1.0</source><value>validator</value></role>
<date><dateTime>2016-05-23T11:37:19Z</dateTime></date>
</contribute>
<metadataSchema>LOMv1.0</metadataSchema>
<language>gre</language>
</metaMetadata>
<rights>
<cost>no</cost>
<copyright>no</copyright>
<description>Copyright EYD-EPEDBM (Operational Programme "Education and Lifelong Learning")</description>
</rights>
</lom>